Skip to content

Clinical trials

Phase 1 Narcolepsy trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Narcolepsy Phase: Phase 1 Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20121
20142
20181
20191
20202
20211
20231
20243
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Terminated2
Recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC3
Vallon Pharmaceuticals, Inc.2
Axsome Therapeutics, Inc.1
Brigham and Women's Hospital1
Concert Pharmaceuticals1
Eisai Inc.1
H. Lundbeck A/S1
Harmony Biosciences Management, Inc.1
Jazz Pharmaceuticals1
Otsuka Pharmaceutical Development & Commercialization, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Narcolepsy16
Disorders of Excessive Somnolence3
Attention Deficit Disorder with Hyperactivity2
Brain Injuries, Traumatic1
Sleep Apnea, Obstructive1

Trials

Showing 26 to 16 of 16. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.